论文部分内容阅读
卡维地洛在美国推荐用于充血性心力衰竭据报道，卡维地洛已在美国被推荐准许用于一种新的适应症，即充血性心力衰竭（CHF）的治疗。SmithKlineBeecham公司的卡维地洛（商品名Coreg）现已在美国被批准用于治疗高血压，但尚未上市。在迄今为止已进行的少数CHF病人的研究中，卡维
Carvedilol Recommended for Congestive Heart Failure in the United States Carvedilol has reportedly been recommended in the United States for the treatment of a new indication, congestive heart failure (CHF). Carvedilol from SmithKline Beecham (Coreg) is now approved for treatment of hypertension in the United States but is not yet available. In the few studies of CHF patients that have been conducted to date, Carvi et al